Eating Disorder Insurance Denials: Fighting Fail-First Step Therapy Under MHPAEA

Why eating disorder denials carry different stakes

Most behavioral health insurance denials are financially painful and clinically disruptive. Eating disorder denials can be lethal. Anorexia nervosa has a standardized mortality ratio of approximately 5.9 — meaning people with anorexia die at roughly six times the rate of matched peers in the general population — making it the most deadly of any psychiatric diagnosis. (Journal of the American Academy of Psychiatry and the Law, 2017)

An investigative report published in May 2025 documented providers describing patients instructed by their insurers to fail five or six outpatient programs — including modalities lacking scientific support — before the plan would authorize residential treatment. At a critically low body weight, the time spent cycling through unsuccessful outpatient attempts is not clinically neutral: medical instability compounds during the delay.

This is not an oversight. It is a structural insurance practice, and MHPAEA has a specific legal framework for challenging it.

Why step therapy is a parity violation — the legal structure

Step therapy (also called fail-first) is a non-quantitative treatment limitation (NQTL) under MHPAEA. An NQTL is any restriction on the scope or duration of care that isn't expressed as a simple number — a visit cap, a dollar limit, a copayment. It includes prior authorization rules, medical necessity criteria, provider network standards, and step therapy requirements.

Under 29 CFR § 2590.712(c)(4), an NQTL applied to mental health or substance use disorder benefits must not be “more restrictive” than the predominant NQTL applied to substantially all analogous medical/surgical benefits. The operative test is a comparison: does the plan require a patient with a medical condition of comparable clinical urgency to fail multiple treatments before accessing inpatient care?

The answer, almost universally, is no. Plans do not require a patient presenting with uncontrolled diabetes, unstable cardiac arrhythmia, or acute kidney injury to first fail outpatient management before authorizing inpatient admission. The decision to admit is made on clinical criteria — current metabolic status, trajectory, and risk — not on a predetermined sequence of treatment failures. Requiring an eating disorder patient to fail IOP, then PHP, then document multiple treatment failures before accessing residential care applies a restriction with no medical/surgical analog. That is the NQTL parity violation.

The DOL's 2024 MHPAEA Report to Congress (published January 2025) explicitly named step therapy protocols and fail-first policies as a priority NQTL enforcement area and identified nutritional counseling exclusions for eating disorders as an example of impermissible benefit restrictions. In 2024 alone, EBSA issued 17 initial letters requesting comparative analyses, 45 insufficiency letters, and 13 initial determinations of parity violations against specific plans.

Levels of care and the codes that get denied

Eating disorder treatment follows a continuum-of-care model. Payers typically try to push patients to the lowest (least intensive) level at every step. The table below maps each level to its most common billing codes and the parity argument when the plan denies or downgrades.

The most strategically important row in this table is residential. When a plan denies residential treatment citing “not medically necessary — patient has not attempted lower levels of care,” that sentence is the parity violation written out in plain English.

How to use the CAA 2021 § 203 demand in an eating disorder appeal

The strategy is identical to any other MHPAEA appeal, described in detail in the cornerstone MHPAEA parity guide, but the eating disorder context gives the demand extra leverage. The key is to name the comparator precisely.

Include this paragraph in every eating disorder appeal that involves a level-of-care denial or a step-therapy requirement:

Under § 203 of the Consolidated Appropriations Act of 2021, codified at 29 U.S.C. § 1185a(a)(8), this plan is required to produce a written comparative analysis of the non-quantitative treatment limitation applied to this claim. I am requesting that written comparative analysis, including the specific step-therapy protocol applied to eating disorder residential treatment and the documentation of whether an equivalent step-therapy requirement applies to inpatient admission for any medical condition of comparable mortality risk — including but not limited to acute kidney injury, unstable cardiac arrhythmia, or malignant hypertension. Anorexia nervosa has a standardized mortality ratio of approximately 5.9 (JAAPL, 2017). Please identify the analogous medical condition for which this plan requires documented failure of two or more outpatient treatment levels before authorizing inpatient care. Please respond within 30 days.

This language does two things the generic demand doesn't. First, it names specific medical comparators, making it impossible for the plan to claim the comparison is inapposite. Second, it puts the mortality statistic in the letter — creating a record that the plan was on notice of the clinical stakes.

What to attach: the clinical record that wins

The parity argument establishes the legal framework. The clinical record establishes that this specific patient's presentation warrants the requested level of care right now, without requiring additional treatment failures. The two parts of the appeal must work together.

Document the following specifically — vague clinical summaries lose appeals; objective data wins them:

1. Weight trajectory. Current weight as percentage of ideal body weight (IBW) or BMI, with trend data showing rate of decline or failure to gain. A patient losing 1–2 lbs per week in outpatient is not stable enough for IOP; document the trend, not just the snapshot.
2. Vital sign instability. Bradycardia (< 50 bpm), orthostatic hypotension (drop > 20 mmHg systolic on standing), hypothermia, or electrolyte abnormalities (potassium, phosphorus, magnesium) are objective medical indicators that document residential-level medical need. Attach recent labs and vitals.
3. Prior treatment history, if any. If the patient has attempted outpatient, document what was tried and what the specific clinical outcomes were. If this is a first presentation at critical weight, document why starting at IOP is clinically contraindicated — the parity argument is that the plan's step requirement is inapplicable here, not just that the patient failed it.
4. Psychiatric comorbidities. Major depressive disorder, OCD, or PTSD co-occurring with an eating disorder raises the clinical complexity and the risk of outpatient deterioration. Include the co-diagnoses in the appeal header.
5. The treating clinician's level-of-care recommendation. A clear statement: “In my clinical judgment, this patient requires residential treatment based on [objective criteria above]. Initiating care at a lower level of care would put the patient at immediate medical risk.” Use specific numbers, not hedged language.

State parity laws that go further

Several states have enacted eating-disorder-specific coverage mandates that apply to fully-insured plans independently of federal MHPAEA. If your patient's plan is fully-insured (check the insurance card — it will list a state-licensed carrier rather than a self-funded ERISA plan), add the relevant state citation alongside the federal MHPAEA argument.

California. SB 855 (2020, effective 2021) requires insurers to cover medically necessary treatment for eating disorders at all levels of care, including residential. It explicitly prohibits step-therapy requirements that would preclude the medically indicated level of care. See California parity appeal guide.

New York. NY Ins. Law § 3221(l)(5) mandates parity for eating disorder benefits including all levels of care. New York also passed Timothy's Law amendments that explicitly address residential mental health and eating disorder benefits. See New York parity appeal guide.

Illinois, Massachusetts, Oregon, and Washington all have parity statutes that require coverage of mental health conditions at all clinically necessary levels of care without discriminatory step requirements. For all other states, federal MHPAEA is the floor.

When the plan stalls: escalation paths

If the plan denies the first-level appeal without producing a comparative analysis, or produces one that doesn't address the step-therapy question, you have three escalation paths. Given the medical stakes in eating disorder cases, file all three simultaneously rather than sequentially.

External independent review (IRO). Federal and state law guarantee access to independent external review when an internal appeal is denied on medical necessity grounds. The IRO uses clinical reviewers with no relationship to the plan. For eating disorder residential denials, external review overturn rates are higher than for general behavioral health because the clinical standard of care is well-established. File immediately after first internal appeal denial.

State Department of Insurance complaint (fully-insured plans). Your state DOI has direct authority over fully-insured plans. A complaint that specifically names the step-therapy NQTL and the plan's failure to produce a CAA 2021 comparative analysis typically produces a response within days. California's Department of Managed Health Care has an expedited process for urgent medical situations — use it.

DOL EBSA complaint (self-funded ERISA plans). File at askebsa.dol.gov. EBSA does not adjudicate individual cases but investigates patterns of parity violations. A complaint is most useful as leverage: notifying the plan that a federal complaint has been filed often accelerates internal resolution. Given that EBSA issued 13 parity violation determinations in 2024 based on comparative-analysis failures, plans with weak analyses have real exposure.

FAQ